Answer
Based on the information you supplied from the Business Wire release titled “Organon Reports Results for the Second Quarter Ended June 30, 2025,” the article only states that Organon (OMN) shared its Q2 2025 results. The brief summary and the metadata (title, symbol, category, provider, and publication timestamp) do not include any details about the company’s forward‑looking statements, such as:
- FY 2025 revenue, earnings, or cash‑flow guidance
- Outlook for the second half of FY 2025 (the period after June 30, 2025)
- Guidance for FY 2026 or any later fiscal years
Because the excerpt you provided does not contain any mention of a guidance or outlook, we cannot confirm that Organon offered any FY 2025 or beyond guidance in this particular release.
What this means for you
- If you need the guidance: You would have to locate the full press release (or the accompanying investor presentation/earnings call transcript) to see whether Organon included any forward‑looking metrics or commentary.
- If you are preparing an analysis: At this point, you should note that the Q2 2025 results are the only information available from this source, and any forecasts for FY 2025 or later would need to be derived from other filings (e.g., the company’s 10‑K, 10‑Q, or a subsequent earnings release that explicitly provides guidance).
Bottom line: The provided news snippet does not contain any guidance or outlook for FY 2025 or beyond. To answer definitively, you would need to review the complete press release or other recent investor communications from Organon.